Does BICALUTAMIDE Cause Metastases to bone? 164 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Metastases to bone have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 4.0% of all adverse event reports for BICALUTAMIDE.
164
Reports of Metastases to bone with BICALUTAMIDE
4.0%
of all BICALUTAMIDE reports
26
Deaths
23
Hospitalizations
How Dangerous Is Metastases to bone From BICALUTAMIDE?
Of the 164 reports, 26 (15.9%) resulted in death, 23 (14.0%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does BICALUTAMIDE Cause?
Malignant neoplasm progression (352)
Prostatic specific antigen increased (322)
Drug ineffective (268)
Fatigue (258)
Prostate cancer (258)
Asthenia (223)
Hot flush (219)
Off label use (171)
Disease progression (169)
Anaemia (164)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which BICALUTAMIDE Alternatives Have Lower Metastases to bone Risk?
BICALUTAMIDE vs BICTEGRAVIR
BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BICALUTAMIDE vs BILASTINE